Dhampur Bio Organics Approves ₹305 Crore Business Transfer and Joint Venture Formation

2 min read     Updated on 22 Apr 2026, 08:10 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dhampur Bio Organics Limited's board approved the transfer of its Meerganj sugar factory to Forever Global Enterprises Limited for ₹305 crores, representing 15.52% of total turnover. The company also authorized a joint venture with Orgonew Private Limited for functional food products, holding 74% stake. Key leadership changes include Mr. Sandeep Kumar's transition to Non-Executive Director and Mr. Nalin Kumar Gupta's appointment as Whole Time Director, both effective May 5, 2026. An Extraordinary General Meeting is scheduled for May 18, 2026, for shareholder approval.

powered bylight_fuzz_icon
38371201

*this image is generated using AI for illustrative purposes only.

Dhampur Bio Organics Limited announced a series of strategic decisions following its board meeting held on April 20, 2026. The company has approved the transfer of its sugar manufacturing unit and entered into a joint venture agreement, marking significant developments in its business strategy.

Business Transfer Details

The board approved the transfer of the company's sugar factory located at Meerganj, Bareilly, Uttar Pradesh, to Forever Global Enterprises Limited on a slump sale basis. The transaction involves transferring the business undertaking as a going concern without assigning individual values to relevant assets and liabilities.

Parameter: Details
Consideration Amount: ₹305.00 crores
Unit Location: Meerganj, Bareilly, Uttar Pradesh
Buyer: Forever Global Enterprises Limited
Transaction Type: Slump sale basis
Expected Completion: Within 60 days from agreement execution

The Meerganj unit contributes 15.52% to the company's total turnover, representing ₹423.24 crores out of the total turnover of ₹2,714.40 crores as per the audited financial statements for March 31, 2025. The buyer is not related to the promoter or promoter group, and the transaction does not fall under related party transactions.

Joint Venture Formation

The board authorized entering into a joint venture with Orgonew Private Limited for developing, manufacturing, marketing, and distributing phyto bio-active based functional food products. The partnership will focus on products meant for human consumption, leveraging Orgonew's proprietary nano-curcumin coating platform and the company's manufacturing infrastructure.

Aspect: Details
Joint Venture Partner: Orgonew Private Limited
Dhampur's Stake: 74%
Orgonew's Stake: 26%
Product Focus: Phyto bio-active functional food products
Key Products: Curcumin-coated low-GI sugar

The joint venture will utilize the company's commercial reach across General Trade, Modern Trade, E-Commerce, and Q-Commerce channels. Orgonew Private Limited is not related to the promoter, promoter group, or any group company.

Leadership Changes

Significant changes in the company's leadership structure were approved, effective May 5, 2026. Mr. Sandeep Kumar will transition from his current role as Whole Time Director to Non-Executive Director upon completion of his tenure. He brings over 45 years of experience in operations, projects, and administration to his new role.

Simultaneously, Mr. Nalin Kumar Gupta has been appointed as Additional and Whole Time Director for a three-year term from May 5, 2026, to May 4, 2029. Currently serving as Chief Financial Officer, Mr. Gupta is a Chartered Accountant with over 25 years of experience in finance, accounts, taxation, and treasury management. He has been associated with the company for more than two decades.

Committee Restructuring

The board approved amendments to the constitution and structure of the Risk Management Committee and Corporate Social Responsibility Committee effective May 5, 2026. The restructured committees will include new member compositions to align with the leadership changes.

Committee: New Structure
CSR Committee: Mrs. Bindu Vashist Goel (Chairperson), Mr. Nalin Kumar Gupta (Member), Mrs. Ruchika Amrish Mehra Kothari (Member)
Risk Management: Mr. Ashwani Kumar Gupta (Chairman), Mr. Gautam Goel (Member), Mr. Vishal Saluja (Member), Mr. Nalin Kumar Gupta (Member)

Shareholder Approval Process

An Extraordinary General Meeting has been scheduled for Monday, May 18, 2026, to seek shareholder approval for the proposed transactions and appointments. The business transfer is subject to receipt of requisite approvals, including from shareholders, and compliance with Regulation 37A of the Listing Regulations. The board meeting commenced at 3:45 PM IST and concluded at 4:45 PM IST on April 20, 2026.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+2.25%-1.02%+18.81%+50.47%+62.52%-30.10%

How will Dhampur Bio Organics deploy the ₹305 crores from the sugar unit sale to strengthen its remaining business segments?

What market potential does the curcumin-coated low-GI sugar product have in India's growing health-conscious consumer segment?

Will the divestment of the 15.52% revenue-contributing Meerganj unit impact Dhampur's competitive position in the sugar industry?

Dhampur Bio Organics Submits Q4FY26 SEBI Depositories Certificate Confirming No Physical Share Holdings

1 min read     Updated on 07 Apr 2026, 02:27 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dhampur Bio Organics Limited filed its Q4FY26 certificate under SEBI Regulation 74(5) on April 07, 2026, for the quarter ended March 31, 2026. The certificate, confirmed by registrar Alankit Assignments Limited, states that no shares are held in physical form, indicating complete dematerialization of the company's share capital. This filing represents standard regulatory compliance with SEBI Depositories and Participants Regulations.

powered bylight_fuzz_icon
37097845

*this image is generated using AI for illustrative purposes only.

Dhampur bio organics Limited has submitted its quarterly compliance certificate under SEBI Depositories and Participants Regulations for the quarter ended March 31, 2026. The certificate was filed with both BSE Limited and National Stock Exchange of India on April 07, 2026.

Regulatory Compliance Filing

The company filed the mandatory certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This quarterly filing is a standard regulatory requirement for listed companies to confirm the status of their share holdings.

Filing Details: Information
Filing Date: April 07, 2026
Quarter Ended: March 31, 2026
Regulation: SEBI Regulation 74(5)
BSE Scrip Code: 543593
NSE Symbol: DBOL

Share Dematerialization Status

Alankit Assignments Limited, serving as the company's Registrar and Share Transfer Agent, provided confirmation regarding the share holding status. The certificate dated April 01, 2026, contains a crucial confirmation about the company's share structure.

The registrar confirmed that there are no holdings of shares in physical form in the company as of March 31, 2026. This indicates complete dematerialization of the company's share capital, with all shares held in electronic format through depositories.

Key Participants

The filing was signed by Ashu Rawat, Company Secretary and Compliance Officer of Dhampur Bio Organics Limited. The confirmation certificate from the registrar was signed by Kamal Garg, General Manager at Alankit Assignments Limited.

Signatory Details: Role
Ashu Rawat: Company Secretary & Compliance Officer
Kamal Garg: General Manager, Alankit Assignments Limited

This quarterly compliance filing demonstrates the company's adherence to SEBI regulations and confirms the complete electronic holding of its share capital, eliminating any physical share certificates in circulation.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+2.25%-1.02%+18.81%+50.47%+62.52%-30.10%

Will Dhampur Bio Organics' complete share dematerialization improve trading liquidity and attract more institutional investors?

How might the elimination of physical shares impact the company's future corporate actions like stock splits or bonus issues?

Could this full dematerialization status make Dhampur Bio Organics a more attractive target for inclusion in major stock indices?

More News on Dhampur Bio Organics

1 Year Returns:+62.52%